GO:0034687 integrin alphaL-beta2 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034687 describes the integrin alphaL-beta2 complex, a heterodimeric cell-surface adhesion receptor composed of one alphaL (ITGAL) subunit and one beta2 (ITGB2) subunit.
• The complex is also known as LFA-1 (lymphocyte function-associated antigen 1) and is the principal integrin mediating leukocyte adhesion, migration, and immune synapse formation.
• Assembly of the heterodimer requires association between the alpha and beta subunits; the conserved beta2 domain folds correctly only when co-expressed with the alpha subunit.
• Beyond adhesion, the alphaL-beta2 complex can transduce signals that modulate transcriptional programs, for example through interaction with the co-activator JAB1 to regulate AP-1 activity.
• Cross-linking of alphaL-beta2 triggers motile behavior in T lymphocytes, linking the complex directly to cytoskeletal reorganization and cell migration.
• Dysregulation of alphaL-beta2 is implicated in leukocyte adhesion deficiency, autoimmune and inflammatory diseases, and cancer immunology, making it a target for functional genomics and therapeutic screening.
Description
The integrin alphaL-beta2 complex (GO:0034687) is a heterodimeric cell-surface receptor in the integrin family, formed by non-covalent association of the alphaL subunit (ITGAL) and the beta2 subunit (ITGB2). This complex, widely known as LFA-1, is a cellular_component annotation that captures the assembled receptor rather than its individual subunits, and it is the dominant integrin on leukocytes for adhesion to ICAM family ligands. Because the complex sits at the interface between extracellular adhesion and intracellular signaling, it is a central node in immune cell trafficking, activation, and effector function. Researchers study GO:0034687 to understand how leukocytes adhere to endothelium and antigen-presenting cells, how the receptor transmits outside-in signals, and how its dysfunction contributes to immunodeficiency and inflammatory disease. The complex is also a paradigm for integrin heterodimer assembly: the beta2 subunit requires co-expression with an alpha subunit for proper folding of its conserved domain, a finding that shaped models of integrin biosynthesis. From a methods perspective, the alphaL-beta2 complex can be interrogated with adhesion assays, flow cytometry, live imaging, and CRISPR-based perturbation of ITGAL or ITGB2. Its dual role in adhesion and transcriptional modulation through JAB1 further broadens its relevance to immuno-oncology and gene regulation.
integrin alphaL-beta2 complex At A Glance
| GO ID | GO:0034687 |
|---|---|
| GO term | integrin alphaL-beta2 complex |
| Ontology | cellular_component |
| Synonym | alphaL-beta2 integrin complex; Itgal-Itgb2 complex |
| Major function | Leukocyte adhesion, migration, and outside-in signaling as the LFA-1 heterodimer |
| Subunit composition | One alphaL (ITGAL) subunit and one beta2 (ITGB2) subunit |
| Assembly requirement | Beta2 conserved domain folding depends on association with the alpha subunit |
| Signaling partner | Interacts with transcriptional co-activator JAB1 to modulate AP-1 activity |
| Cellular context | Primarily expressed on leukocytes, including T lymphocytes |
What Is GO:0034687?
GO:0034687 is a Gene Ontology cellular_component term defined as an integrin complex that comprises one alphaL subunit and one beta2 subunit. In other words, it is the assembled heterodimer of ITGAL and ITGB2, not the isolated subunits. The term carries synonyms alphaL-beta2 integrin complex and Itgal-Itgb2 complex, reflecting the standard gene nomenclature for the two chains.
Why Is integrin alphaL-beta2 complex Important in Cell Biology?
The integrin alphaL-beta2 complex is important because it is the principal adhesion receptor that allows leukocytes to arrest on endothelium, migrate into tissues, and form productive immune synapses. Its activity is required for T cell motility and for the dynamic cytoskeletal rearrangements that underlie immune surveillance. Beyond adhesion, the complex can initiate outside-in signals that reach the nucleus, as shown by its interaction with JAB1 and modulation of AP-1 activity. Because assembly of the heterodimer is tightly coupled to beta2 subunit folding, the complex also serves as a model for studying integrin biogenesis and quality control.
• Mediates leukocyte adhesion to ICAM ligands and is central to immune cell trafficking.
• Required for T lymphocyte motile behavior and cytoskeletal reorganization upon cross-linking.
• Transmits outside-in signals that can modulate AP-1 transcriptional activity via JAB1.
• Serves as a paradigm for integrin heterodimer assembly and beta2 subunit folding.
• Dysfunction is linked to leukocyte adhesion deficiency and inflammatory pathology.
• Represents a therapeutic target in autoimmune disease and immuno-oncology.
• Enables functional genomics screens for adhesion and migration phenotypes.
• Provides a defined cellular_component annotation for proteomic and imaging studies.
Structure and Composition of integrin alphaL-beta2 complex
Heterodimer architecture
In simple terms: The complex is made of two different protein chains that stick together.
The integrin alphaL-beta2 complex is a non-covalent heterodimer containing one alphaL subunit and one beta2 subunit. Each subunit is a type I transmembrane glycoprotein with a large extracellular domain, a single transmembrane helix, and a short cytoplasmic tail. The extracellular portions together form the ligand-binding headpiece, while the tails connect to the cytoskeleton and signaling machinery.
AlphaL subunit (ITGAL)
In simple terms: AlphaL is the chain that helps recognize the ligand.
The alphaL subunit, encoded by ITGAL, contributes the beta-propeller and I-domain that participate in ligand binding. Its cytoplasmic tail is relatively short and serves as a platform for adaptor and signaling proteins. In the assembled complex, alphaL pairs exclusively with beta2 to form LFA-1.
Beta2 subunit (ITGB2)
In simple terms: Beta2 is the partner chain that stabilizes the complex and signals inside the cell.
The beta2 subunit, encoded by ITGB2, contains a conserved domain whose folding requires association with the alpha subunit. This dependence on heterodimer formation ensures that only properly paired integrins reach the cell surface. The beta2 cytoplasmic tail is a hub for intracellular multi-protein complexes that relay signals.
Assembly and quality control
In simple terms: The two chains must find each other for the receptor to work.
Folding of the conserved domain in beta2 but not of its flanking regions requires co-expression with the alpha subunit, indicating that heterodimer assembly is coupled to subunit maturation. This assembly step is a quality-control checkpoint that prevents unpaired subunits from accumulating. The resulting complex is then trafficked to the plasma membrane as a functional adhesion receptor.
Intracellular multi-protein complexes
In simple terms: The receptor's tail gathers many proteins that carry signals inward.
The beta2 integrin intracellular region nucleates multi-protein complexes that link the receptor to the cytoskeleton and to signaling pathways. Structural studies of beta2 integrin intracellular complexes have clarified how these assemblies are organized. These complexes are essential for converting ligand engagement into cellular responses.
Key Genes Involved in GO:0034687 integrin alphaL-beta2 complex
The following genes and proteins are directly or functionally associated with the integrin alphaL-beta2 complex and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGAL | Encodes the alphaL subunit of the heterodimer | Knockout or point mutation to test adhesion and migration |
| ITGB2 | Encodes the beta2 subunit of the heterodimer | Assembly and folding studies; disease variant modeling |
| ICAM1 | Principal ligand for alphaL-beta2 on endothelium | Adhesion assays and ligand-blocking experiments |
| ICAM2 | Alternative ligand for the complex | Ligand specificity studies |
| ICAM3 | Ligand on leukocytes for LFA-1 | Immune synapse and homotypic adhesion assays |
| JAB1 (COPS5) | Transcriptional co-activator interacting with the complex | AP-1 reporter assays and signaling studies |
| AP-1 components | Transcription factors modulated downstream of the complex | Transcriptional readouts after receptor engagement |
| Talin | Cytoskeletal adaptor linking integrins to actin | Inside-out signaling and adhesion studies |
| Kindlin | Adaptor promoting integrin activation | Activation-state imaging and functional assays |
| Rho GTPases | Regulate cytoskeletal dynamics downstream of adhesion | Migration and motility assays |
| Actin | Cytoskeletal polymer required for motility | Live imaging of T cell movement |
| Integrin alpha4-beta1 | Related integrin cooperating in T cell motility | Comparative cross-linking experiments |
| CD11a | Protein name for the alphaL chain | Flow cytometry and immunoprecipitation |
| CD18 | Protein name for the beta2 chain | Surface expression and maturation assays |
| LFA-1 | Alternative name for the assembled complex | Functional adhesion and immune synapse studies |
| ITGB2 conserved domain | Domain whose folding depends on alpha association | Protein folding and assembly research |
| Cytoplasmic tail interactors | Proteins binding beta2 intracellular region | Proteomic and structural studies |
How Is integrin alphaL-beta2 complex Regulated?
Regulation of the integrin alphaL-beta2 complex occurs at multiple levels. Assembly is regulated by subunit availability, since the beta2 conserved domain folds correctly only when co-expressed with the alpha subunit. At the cell surface, the complex is regulated by inside-out signaling through cytoplasmic tail interactors that form multi-protein complexes. Ligand engagement triggers outside-in signals that can reach the nucleus, as exemplified by the interaction with JAB1 and modulation of AP-1 activity. Cross-linking of the complex also regulates motile behavior in T lymphocytes, linking receptor engagement to cytoskeletal control.
integrin alphaL-beta2 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGB2 | Leukocyte adhesion deficiency | Knockout or point-mutation cell lines |
| ITGAL | Leukocyte adhesion and autoimmunity | Knockout T cell models |
| COPS5 (JAB1) | AP-1-driven transcription in cancer | Overexpression and reporter assays |
| ICAM1 | Inflammatory adhesion | Ligand knock-in or knockout models |
| Rho GTPases | Cell motility in immune disease | Point-mutation migration models |
Leukocyte adhesion deficiency
Defects in the beta2 subunit impair formation of the alphaL-beta2 complex and cause leukocyte adhesion deficiency, characterized by recurrent infections and impaired wound healing. Because beta2 folding depends on alpha association, mutations that disrupt assembly reduce surface expression of the complex. Functional studies of the complex therefore inform diagnosis and mechanistic understanding of this immunodeficiency.
Autoimmune and inflammatory disease
The alphaL-beta2 complex drives leukocyte recruitment into inflamed tissues, making it a therapeutic target in autoimmune and inflammatory conditions. Blocking adhesion or signaling through the complex can reduce pathological immune cell infiltration. Cross-linking studies show that the complex also controls T cell motility, a process central to tissue damage in autoimmunity.
Cancer immunology
Because the complex regulates immune synapse formation and T cell migration, it influences anti-tumor immunity. Signaling through the complex can modulate AP-1 activity via JAB1, linking adhesion to transcriptional programs relevant to tumor immunology. These connections make the complex a candidate target for immuno-oncology research.
From integrin alphaL-beta2 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of the complex abolish leukocyte adhesion? | ITGAL or ITGB2 knockout cell line |
| Does a patient variant impair heterodimer assembly? | Point-mutation knock-in of ITGB2 |
| Can a tagged complex be tracked at the cell surface? | Tagged knock-in of ITGAL or ITGB2 |
| Does overexpression drive AP-1 activity? | Overexpression of ITGAL/ITGB2 with JAB1 |
| Which genes regulate T cell motility downstream? | CRISPR library screening in motile T cells |
| How does ligand engagement change signaling? | Ligand cross-linking with imaging readouts |
How to Study the integrin alphaL-beta2 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Adhesion assay | Binding to ICAM ligands | Testing complex function |
| Migration assay | Motile behavior after cross-linking | T cell motility studies |
| Flow cytometry | Surface expression of CD11a/CD18 | Assembly and maturation analysis |
| Live imaging | Cytoskeletal dynamics | Motility and immune synapse studies |
| Immunoprecipitation | Protein-protein interactions | Intracellular complex mapping |
| Reporter assay | AP-1 transcriptional activity | JAB1-dependent signaling |
| CRISPR screening | Genes required for adhesion/migration | Functional genomics |
Adhesion and migration assays
Adhesion assays measure binding of cells expressing the alphaL-beta2 complex to ICAM ligands, while migration assays quantify motile behavior after receptor cross-linking. These functional readouts are the primary way to test whether the complex is active.
Flow cytometry and surface expression
Flow cytometry with antibodies against CD11a and CD18 quantifies surface expression of the assembled complex and detects assembly defects. This method is widely used to assess whether mutations impair heterodimer formation.
Imaging and cytoskeletal analysis
Live imaging of T lymphocytes after cross-linking of alphaL-beta2 reveals cytoskeletal reorganization and motile behavior. These approaches link receptor engagement to dynamic cell shape changes.
Proteomics and structural analysis
Proteomic and structural studies identify intracellular multi-protein complexes that assemble on the beta2 tail. Such work defines the signaling machinery associated with the complex.
How CRISPR Can Be Used to Study GO:0034687 integrin alphaL-beta2 complex
Knockout
CRISPR knockout of ITGAL or ITGB2 eliminates the alphaL-beta2 complex and provides a clean background to test adhesion, migration, and signaling. Knockout lines are also useful to confirm that observed phenotypes depend on the complex.
Point Mutation
Point mutations can be introduced into ITGB2 to model variants that impair folding or assembly of the conserved domain. Such models help dissect which residues are required for heterodimer formation.
Knock-in
Tagged knock-in of ITGAL or ITGB2 allows tracking of the assembled complex at the cell surface and in intracellular compartments. Knock-in of disease-associated alleles supports mechanistic studies of leukocyte adhesion deficiency.
Overexpression
Overexpression of ITGAL and ITGB2 together with JAB1 can be used to study downstream AP-1 transcriptional modulation. Overexpression systems also facilitate biochemical purification of the complex.
How EDITGENE Supports integrin alphaL-beta2 complex Research
Researchers studying integrin alphaL-beta2 complex-related genes often need to determine whether a candidate gene is causally involved in adhesion, migration, or signaling, and CRISPR-based models provide the most direct way to test causality.
Contact EDITGENE today to design your custom CRISPR model for integrin alphaL-beta2 complex research.
Frequently Asked Questions About integrin alphaL-beta2 complex
What is the integrin alphaL-beta2 complex?
It is a heterodimeric cell-surface receptor composed of one alphaL (ITGAL) subunit and one beta2 (ITGB2) subunit, also known as LFA-1.
What genes are involved in the integrin alphaL-beta2 complex?
The core genes are ITGAL and ITGB2, which encode the alphaL and beta2 subunits, respectively.
What is GO:0034687?
GO:0034687 is the Gene Ontology cellular_component term for the integrin alphaL-beta2 complex.
What does the integrin alphaL-beta2 complex do?
It mediates leukocyte adhesion to ICAM ligands, supports T cell motility, and can transmit signals that modulate transcription.
Why does beta2 need alphaL for folding?
The conserved domain of beta2 folds correctly only when co-expressed with the alpha subunit, coupling assembly to subunit maturation.
How is the complex linked to transcription?
It interacts with the co-activator JAB1 to modulate AP-1 activity, connecting adhesion to gene regulation.
What diseases involve the integrin alphaL-beta2 complex?
Defects cause leukocyte adhesion deficiency, and the complex contributes to autoimmune, inflammatory, and cancer-related immune processes.
How do researchers study the complex?
Common methods include adhesion and migration assays, flow cytometry, live imaging, proteomics, and CRISPR perturbation.
Can CRISPR knockout be used to study the complex?
Yes, knockout of ITGAL or ITGB2 removes the complex and allows direct testing of its functions.
What models are available for assembly defects?
Point-mutation knock-in of ITGB2 and knockout lines are used to model impaired heterodimer assembly.
Conclusion
The integrin alphaL-beta2 complex (GO:0034687) is a defined heterodimeric cellular_component with essential roles in leukocyte adhesion, motility, and outside-in signaling. Its assembly is coupled to beta2 subunit folding, and its engagement can influence transcription through JAB1 and AP-1. Studying this complex with CRISPR-based models and functional assays provides a direct route to understanding immune cell biology and related diseases.
References
- 1. Bhattacharjya S. 2022. The structural basis of β2 integrin intra-cellular multi-protein complexes.. Biophys Rev 14(5):1183-1195 PMID: 36345283
- 2. Huang C et al.. 1997. Folding of the conserved domain but not of flanking regions in the integrin beta2 subunit requires association with the alpha subunit.. Proc Natl Acad Sci U S A 94(7):3156-61 PMID: 9096362
- 3. Bianchi E et al.. 2000. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.. Nature 404(6778):617-21 PMID: 10766246
- 4. Hauzenberger D et al.. 1997. Triggering of motile behavior in T lymphocytes via cross-linking of alpha 4 beta 1 and alpha L beta 2.. J Immunol 158(1):76-84 PMID: 8977177
